Literature DB >> 28474117

Therapeutic targets in necrotizing soft tissue infections.

Nicolas de Prost1,2, Jeffrey Lipman3, Olivier Mimoz4,5,6.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28474117     DOI： 10.1007/s00134-017-4813-1

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  16 in total

Review 1.  Clinical practice. Cellulitis.

Authors:  Morton N Swartz
Journal:  N Engl J Med       Date:  2004-02-26       Impact factor: 91.245

2.  Prognostic factors in necrotizing soft-tissue infections (NSTI): A cohort study.

Authors:  Camille Hua; Emilie Sbidian; Francois Hemery; Jean Winoc Decousser; Romain Bosc; Roland Amathieu; Alain Rahmouni; Pierre Wolkenstein; Laurence Valeyrie-Allanore; Christian Brun-Buisson; Nicolas de Prost; Olivier Chosidow
Journal:  J Am Acad Dermatol       Date:  2015-09-26       Impact factor: 11.527

3.  Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group.

Authors:  R Kaul; A McGeer; A Norrby-Teglund; M Kotb; B Schwartz; K O'Rourke; J Talbot; D E Low
Journal:  Clin Infect Dis       Date:  1999-04       Impact factor: 9.079

4.  Immunoglobulin G for patients with necrotising soft tissue infection (INSTINCT): a randomised, blinded, placebo-controlled trial.

Authors:  Martin B Madsen; Peter B Hjortrup; Marco B Hansen; Theis Lange; Anna Norrby-Teglund; Ole Hyldegaard; Anders Perner
Journal:  Intensive Care Med       Date:  2017-04-18       Impact factor: 17.440

5.  Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America.

Authors:  Dennis L Stevens; Alan L Bisno; Henry F Chambers; E Patchen Dellinger; Ellie J C Goldstein; Sherwood L Gorbach; Jan V Hirschmann; Sheldon L Kaplan; Jose G Montoya; James C Wade
Journal:  Clin Infect Dis       Date:  2014-07-15       Impact factor: 9.079

6.  Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study.

Authors:  Anna Linnér; Jessica Darenberg; Jan Sjölin; Birgitta Henriques-Normark; Anna Norrby-Teglund
Journal:  Clin Infect Dis       Date:  2014-06-13       Impact factor: 9.079

Review 7.  Sepsis: frontiers in diagnosis, resuscitation and antibiotic therapy.

Authors:  Anders Perner; Anthony C Gordon; Daniel De Backer; George Dimopoulos; James A Russell; Jeffrey Lipman; Jens-Ulrik Jensen; John Myburgh; Mervyn Singer; Rinaldo Bellomo; Timothy Walsh
Journal:  Intensive Care Med       Date:  2016-10-01       Impact factor: 17.440

8.  Intravenous immunoglobulin in children with streptococcal toxic shock syndrome.

Authors:  Samir S Shah; Matthew Hall; Raj Srivastava; Anupama Subramony; James E Levin
Journal:  Clin Infect Dis       Date:  2009-11-01       Impact factor: 9.079

9.  Assessment of functional limitation after necrotizing soft tissue infection.

Authors:  Tam N Pham; Merilyn L Moore; Beth A Costa; Joseph Cuschieri; Matthew B Klein
Journal:  J Burn Care Res       Date:  2009 Mar-Apr       Impact factor: 1.845

10.  Impact of Intravenous Immunoglobulin on Survival in Necrotizing Fasciitis With Vasopressor-Dependent Shock: A Propensity Score-Matched Analysis From 130 US Hospitals.

Authors:  Sameer S Kadri; Bruce J Swihart; Stephanie L Bonne; Samuel F Hohmann; Laura V Hennessy; Peter Louras; Heather L Evans; Chanu Rhee; Anthony F Suffredini; David C Hooper; Dean A Follmann; Eileen M Bulger; Robert L Danner
Journal:  Clin Infect Dis       Date:  2017-04-01       Impact factor: 9.079
View more
  5 in total

1.  Intensive multidisciplinary management in critical care patients affected by severe necrotizing soft tissue infections: a cooperative method to improve the efficacy of treatment.

Authors:  Milo Gatti; Laura Elisa Gasparini; Matteo Laratta; Anna Sigurtà; Anna Rossi; Paolo Brioschi; Osvaldo Chiara; Chiara Vismara; Francesco Scaglione; Sergio Arlati
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-03-06       Impact factor: 3.267

2.  Contribution of Topical Agents such as Hyaluronic Acid and Silver Sulfadiazine to Wound Healing and Management of Bacterial Biofilm.

Authors:  Francesco De Francesco; Michele Riccio; Shiro Jimi
Journal:  Medicina (Kaunas)       Date:  2022-06-20       Impact factor: 2.948

3.  Necrotizing soft tissue infection: clinical characteristics, diagnosis, and management of 32 cases in Beijing.

Authors:  Zhen Cui; Shuai Lu; Ying Bai; Xu Sun; Peng Tian; Ying Liu; Lu Mao; Xieyuan Jiang
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

4.  Necrotizing Fasciitis: A Life-Threatening Infection Due to Clostridium Species.

Authors:  Sharon Hechter; Vraj Patel; Veera Jayasree Latha Bommu; Priya Patel; Xue Ao; Dina Alnabwani; Pramil Cheriyath
Journal:  Cureus       Date:  2022-02-17

5.  Early identification of patients at high risk of group A streptococcus-associated necrotizing skin and soft tissue infections: a retrospective cohort study.

Authors:  Tomas Urbina; Camille Hua; Paul-Louis Woerther; Armand Mekontso Dessap; Olivier Chosidow; Nicolas de Prost
Journal:  Crit Care       Date:  2019-12-21       Impact factor: 9.097
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.